Cancer Immunology and Immunotherapy

Cellular immunity depends mainly on the power of DCs to require up and process antigens within the peripheral blood and tissues. In cancer, this process isn't robust enough to supply meaningful antitumor responses. Monoclonal antibodies are proteins produced by B-cells that bind to a selected antigen. they're currently one among the foremost successful sorts of cancer immunotherapy. we should always differentiate between monoclonal antibody-based cancer therapy and monoclonal antibody-based immunotherapy of cancer. this will be illustrated by the differences in their mechanisms of action. Anti-neoplastic agents like bevacizumab block ligand–receptor interaction, thereby affecting growth or survival pathways, where monoclonal antibodies like rituximab cause antibody-dependent cellular cytotoxicity and complement-mediated cytotoxicity. Antibodies also are getting used to reinforce the strength of the immune reaction. As mentioned earlier, activated T-cells and tumour cells express CTLA4 receptors as an immune-suppressive mechanism to guard against autoimmunity and to flee elimination. Antagonism of those receptors has shown antitumor benefit. for instance, ipilimumab inhibits the receptor CTLA4, permitting persistent T-cell activation. Similarly, PD1 is expressed on activated T- and B-cells and when sure to by PD1 ligand they become deactivated (10-12). Tumour cells tend to overexpress PD1 ligands, allowing them to deactivate this response.

  • Cell-based immunotherapy of cancer
  • Antibody-based immunotherapy of cancer
  • Cytokine-based immunotherapy of cancer
  • Anti CTLA4
  • Anti-PD1
  • Hodgkin's lymphoma

    Related Conference of Cancer Immunology and Immunotherapy

    February 04-05, 2026

    18th International Conference on Gynecology

    Rome, Italy
    February 25-26, 2026

    15th International Conference on Herbal Medicine and Acupuncture

    Aix-en-Provence, France
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 24-25, 2026

    9th Global Congress on Spine and Spinal Disorders

    Paris, France
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    April 27-28, 2026

    40th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    April 27-28, 2026

    37th World Congress on Neurorehabilitation

    Dubai, UAE
    May 25-26, 2026

    18th International Conference on Clinical Chemistry

    Zurich, Switzerland
    September 14-15, 2026

    6th World Medicine Congress

    Rome, Italy
    November 24-25, 2026

    6th International Conference on Medical Research and Development

    Amsterdam, Netherlands

    Cancer Immunology and Immunotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in